Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Icon (ICLR)

Analysts from TD Cowen and TipRanks – DeepSeek have issued “Buy” ratings for Amgen (AMGN), with price targets indicating a potential upside from current levels. For Icon (ICLR), Truist Financial and Barclays maintained “Hold” ratings, with their price targets also suggesting a modest upside. These ratings reflect recent insights into these healthcare companies.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin